Detalhe da pesquisa
1.
Nonclinical safety of mavrilimumab, an anti-GMCSF receptor alpha monoclonal antibody, in cynomolgus monkeys: relevance for human safety.
Toxicol Appl Pharmacol
; 279(2): 230-9, 2014 Sep 01.
Artigo
Inglês
| MEDLINE | ID: mdl-24937321